Abstract
Anosocomial infection (NI) is defined as an infection that is not present or incubating when the patient is admitted to a hospital or other health care facility.1 Generally, an infection that is discovered 48–72 h after admission is indicative of nosocomial, rather than community-acquired, infection. Although usually associated with hospital admission (hence the term hospital-acquired infection), Ms can arise after admission to any health care facility, and the term health care-associated infection is now preferred. Nosocomial infections are increasingly considered as a measure of quality of care and are the focus of safety and quality improvements efforts in many hospitals today.2–8 To date, the extent these NIs are avoidable under real-life hospital conditions and what represents the irreducible minimum remain unclear.9–11 A number of observational studies implementing multimodality strategies and standardized policies and practices have demonst rated a 10% to 70% reduction in infection rates depending on the setting, study design, type of infection, and baseline infection rates.9–15
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Garner J, Jarvis W, Emori T, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.
CDC. Public health focus: surveillance, prevention and control of nosocomial infections. MMWR Morb Mortal Wkly Rep 1992;41:783–787.
Vincent J. Nosocomial infections in the adult intensive care unit. Lancet 2003;361:2068–2077.
Kohn L, Corrigan J, Donaldson M. To Err Is Human: Building a Safer Health System. Washington, DC: Institute of Medicine, National Academy Press, 1999.
Gaynes R, Solomon S. Improving hospital-acquired infection rates: the CDC experience. JCAHO J Quality Improvement 1996;22:457–467.
CDC. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990–May 1999. Am J Infect Control 1999;27:520–532.
Eggimann P, Pittet D. Infection control in the ICU. Chest 2001;120:2059–2093.
Eggimann P, Sax H, Pittet D. Catheter-related infection. Microbes Infect 2004;6:1033–1042.
Berenholtz S, Pronovost P, Lipsett P, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32:2014–2020.
National Center for Health Statistics. Healthy People 2000 Review 1998–1999. Hyattsville, MD: U.S. Department of Health and Human Services, CDC, 2000.
Culver D, White J, Morgan W, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in U.S. hospitals. Am J Epidemiol 1985;121:182–205.
Eggimann P, Harbarth S, Constantin M, et al. Impact of a prevention strategy targeted at vascular access care on incidence of infections acquired in intensive care. Lancet 2000;355:1864–1868.
Hacek D, Suriano T, Noskin G, et al. Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonality. Am J Clin Pathol 1999;111:647–654.
Dumigan D, Kohan C, Reed C, et al. Utilizing national nosocomial infection surveillance system data to improve urinary tract infection rates in three intensive-care units. Clin Perform Qual Health Care 1998;6:172–178.
McConkey S, L’Ecuyer P, Murphy D, et al. Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol 1999;8:533–538.
NNIS System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.
Saint S, Savel R, Matthay M. Enhancing the safety of critically ill patients by reducing urinary and central venous catheter-related infections. Am J Respir Crit Care Med 2002;165:1475–1479.
Wenzel R, Edmond M. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001;7:174–177.
U. S. Department of Health and Human Services. Healthy People 2010, U.S. Department of Health and Human Services, conference ed. Washington, DC: U.S. Department of Health and Human Services, 2000.
Monitoring hospital-acquired infections to promote patient safety-United States, 1990–1999. MMWR Morb Mortal Wkly Rep 2000;49:149–153.
Stone P, Larson E, Nijab Kawar L. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990–2000. Am J Infect Control 2002;30:145–152.
Vincent J, Bihari D, Suter P, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995;274:639–644.
Döcke W, Randow F, Syrbe H, et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat Med 1997;3:678–681.
Asadullah K, Woiciechowsky C, Docke W, et al. Immunodepression following neurosurgical procedures. Crit Care Med 1995;23:1976–1983.
Schinkel C, Sendtner R, Zimmer S, et al. Functional analysis of monocyte subsets in surgical sepsis. J Trauma 1998;44:743–748.
Peters M, Petros A, Dixon G, et al. Acquired immunoparalysis in paediatric intensive care: prospective observational study. BMJ 1999;319:609–610.
Bonten M, Kollef M, Hall J. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 2004;38:1141–1149.
Beck-Sague C, Sinkowitz R, Chinn R, et al. Risk factors for ventilator-associated pneumonia in surgical intensive care-unit patients. Infect Control Hosp Epidemiol 1994;17:374–376.
Craven D, Kunches L, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986;133:792–796.
Torres A, Gatell J, Aznar E, et al. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995;152:137–141.
Rello J, Sonora R, Jubert P, et al. Pneumonia in intubated patients: role of respiratory airway care. Am J Respir Crit Care Med 1996;154:111–115.
Donskey C. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 2004;39:219–226.
Vollaard E, Clasener H. Colonization resistance. Antimicrob Agents Chemother 1994;38:409–414.
Hendrix C, Hammond J, Swoboda S, et al. Surveillance strategies and impact of vancomycin-resistant enterococcal (VRE) colonization and infection in critically ill patients. Ann Surg 2001;233:259–265.
Pelz R, Lipsett P, Swoboda SM, et al. The diagnostic value of fungal surveillance cultures in critically ill patients. Surg Infect 2000;1:273–281.
Ray A, Pultz N, Bhalla A, et al. Coexistence of vancomycin-resistant Entewcoccus and Staphylococcus aureus in the intestinal tracts of hospitalized patients. Clin Infect Dis 2003;37:875–881.
Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003;54:243–245.
Estes R, Meduri G. The pathogenesis of ventilator-associated pneumonia, 1: mechanisms of bacterial transcolonization and airway inoculation. Intensive Care Med 1995;21:365–383.
Livrelli V, De Champs C, Di Martino P, et al. Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections. J Clin Microbiol 1996;34:1963–1969.
Wang J, Chang S, Ko W, et al. A hospital-acquired outbreak of methicillin-resistant Staphylococcus aureus infection initiated by a surgeon carrier. J Hosp Infect 2001;47:104–109.
Pettinger A, Nettleman M. Epidemiology of isolation precautions. Infect Control Hosp Epidemiol 1991;12:303–307.
Pittet D. Improving adherence to hand hygiene practice: a multidisciplinary approach. Emerg Infect Dis 2001;7:225–240.
Lipsett P, Swoboda S. Handwashing compliance depends on professional status. Surg Infect 2001;2:241–245.
Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356:1307–1290.
Pittet D, Mourouga P, Perneger T, et al. Compliance with handwashing in a teaching hospital. Ann Intern Med 1999;130:126–130.
Swoboda S, Earsing K, Strauss K, et al. Electronic monitoring and voice prompts improve hand hygiene and decrease nosocomial infections in an intermediate care unit. Crit Care Med 2004;32:358–363.
Streit J, Jones R, Sader H, et al. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 2004;24:111–118.
Emori T, Edwards J, Culver D, et al. Accuracy of reporting nosocomial infections in intensive care unit patients to the National Nosocomial Infections Surveillance (NNIS) system: a pilot study. Infect Control Hosp Epidemiol 1998;19:308–316.
Jarvis W. Benchmarking for prevention: the Centers for Disease Control and Prevention’s National Nosocomial Infections Surveillance (NNIS) system experience. Infection 2003;suppl 2:44–48.
Kaoutar B, Joly C, L’Heriteau F, et al. Nosocomial infections and hospital mortality: a multicenter epidemiological study. J Hosp Infect 2003;58:269–272.
The American Thoracic Society and Infectious Disease Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388–416.
Kollef M. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004;32:1396–1405.
Kollef M. Epidemiology and risk factors for nosocomial pneumonia. Emphasis on prevention. Clin Chest Med 1999;20:653–670.
Kollef M. The prevention of ventilator-associated pneumonia. N Engl J Med 1999;340:627–634.
Zack J, Garrison T, Trovillion E, et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002;30:2407–2412.
Cook D, Kollef M. Risk factors for ICU-acquired pneumonia. JAMA 1998;279:1605–1606.
Messori A, Trippoli S, Vaiani M, et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 2000;321:1103–1106.
Ben-Menachem T, Fogel R, Patel R, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study. Ann Intern Med 1994;121:568–575.
Eddleston J, Pearson R, Holland J, et al. Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo. Crit Care Med 1994;22:1949–1954.
Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998;338:791–797.
Bonten M, Bergmans D, Ambergen A, et al. Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. Am J Respir Crit Care Med 1996;154:1339–1346.
Garrouste-Oregas M, Chevret S, Arlet G, et al. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients: a prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 1997;156:1647–1655.
Heyland D, Drover J, Dhaliwal R, Greenwood J. Optimizing the benefits and minimizing the risks of enteral nutrition in the critically ill: role of small bowel feeding. JPEN J Parenter Enteral Nutr 2002;26:S51–S55.
Dodek P, Keenan S, Cook D, et al. Evidenced-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 2004;141:305–313.
Drakulovic M, Torres A, Bauer T, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999;354:1851–1858.
Cook D, Walter S, Cook R, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433–440.
Hernandez G, Rico P, Diaz E, et al. Nosocomial lung infections in adult intensive care units. Microbes Infect 2004;6:1004–1014.
Marik P, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia, and aspiration pneumonia: a prospective study. Chest 1999;115:178–183.
Hubmair. R. Statement of the Fourth International Consensus Conference in Critical Care on ICU-Acquired Pneumonia, Chicago, IL, May 2002. Intensive Care Med 2002;28:1521–1536.
Michaud S, Suzuki S, Harbath S. Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;166:1320–1325.
Waterer G, Wunderink R. Controversies in the diagnosis of ventilator-associated pneumonia. Med Clin North Am 2001;85:1565–1581.
Mehta R, Niederman M. Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. J Intensive Care Med 2003;18:175–188.
Fagon J, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 2000;132:621–630.
Sole Violan J, Fernandez J, Benitez A, et al. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 2000;28:2737–2741.
Baughman R, Thorpe J, Staneck J, et al. Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes. Chest 1987;91:233–236.
Chastre J, Fagon J, Soler P, et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med 1988;85:499–450.
Fagon J. Hospital-acquired pneumonia: diagnostic strategies: lessons from clinical trials. Infect Dis Clin N Am 2003:17;717–726.
Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator associated pneumonia by bacteriologic analysis of bronchoscope and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143:1121–1129.
Heyland D, Cook D, Marshall J, et al. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group. Chest 1999;115:1076–1084.
Sanchez-Nieto J, Torres A, Garcia-Cordoba F, et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med 1998;157:371–376.
Ruiz M, Torres A, Ewig S, et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 2000;162:119–125.
Pingleton S, Fagon J, Leeper K Jr. Patient selection for clinical investigation of ventilator-associated pneumonia: criteria for evaluating diagnostic techniques. Chest 1992;102:553S–556S.
Meduri G, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 1992;102:557S–564S.
Shorr A, Sherner J, Jackson W, et al. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2005;33:46–53.
Singh N, Rogers P, Atwood C, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505–511.
Sole-Violan J, Fernandez J, Benitez A, et al. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 2000;28:2737–2741.
Rello J, Paiva J, Baraibar K, et al. International Conference for the Development of the Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia. Chest 2001;120:955–970.
Luna C, Vujacich P, Niederman M, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111:676–685.
Ibrahim E, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001;29:1109–1115.
Micek S, Ward S, Fraser V, et al. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004;125:1791–1799.
Wunderink R, Cammarata S, Oliphant T, et al. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 2003;25:980–992.
Rubinstein E, Cammarata S, Oliphant T, et al. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 2001;32:402–412.
Heyland D, Cook D, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999;159:1249–1256.
Fagon J, Chastre J, Hance A, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281–288.
Baker A, Meredith J, Haponik E. Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med 1996;153:343–349.
Cunnion K, Weber D, Broadhead W, et al. Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med 1996;153:158–162.
Craig C, Connelly S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control 1984;12:233–238.
Kappstein I, Schulgen G, Beyer U, et al. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992;11:504–508.
Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996;154:91–97.
Pittet D, Tarara D, Wenzel R. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.
Heyland D, Cook D, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999;159:1249–1256.
Dimick J, Pelz R, Consunji R, et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001;136:229–234.
Harbath S, Garbino J, Pugin J, et al. Inappropriate initial antibiotic therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003;115:529–535.
Farr B. Prevention and control of methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis 2004;17:317–322.
Garner J, Jarvis W, Emori T, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128–140.
O’Grady N, Alexander M, Dellinger E, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 2002;51:1–29.
Wisplinghoff H, Bischoff T, Tallent S, et al. Nosocomial bloodstream infections in U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309–317.
Mermel L, Farr B, Sherertz R, et al. Infectious Diseases Society of America, American College of Critical Care Medicine, and Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter related infections. Clin Infect Dis 2001;32:1249–1272.
Cobb D, High K, Sawyer R, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992;327:1062–1068.
Raad I, Hohn D, Gilbreath B, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231–238.
Maki D, Ringer M, Alvarado C. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339–343.
Darouiche R, Raad I, Heard S, et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999;340:1–8.
Veenstra D, Saint S, Sullivan S. Cost-effectiveness of antiseptic-impregnated central venous catheter for the prevention of catheter-related bloodstream infection. JAMA 1999;282:554–560.
Veenstra D, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. A meta-analysis. JAMA 1999;281:261–267.
Maki D, Stolz, S, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997;127:257–266.
Raad I, Darouiche R, Dupuis J, et al. A central venous catheter coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann Intern Med 1997;127:267–274.
Sherertz R, Ely E, Westbrook D, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000;132:641–648.
Coopersmith C, Rebmann T, Zack J, et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002;30:59–64.
Warren D, Zack J, Cox M, et al. An educational intervention to prevent catheter-associated bloodstream infections in a non-teaching, community medical center. Crit Care Med 2003;31:1959–1963.
Warren J. Catheter-associated urinary tract infections. Int J Antimicrob Agents 2001;17:299–303.
Stamm W. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med 1991;91:65S–71S.
Haley R, Hooton T, Culver D, et al. Nosocomial infections in U.S. hospitals, 1975–1976: estimated frequency by selected characteristics of patients. Am J Med 1981;70:947–59.
Saint S, Wiese J, Amory J, et al. Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med 2000;109:476–480.
Warren J. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997;11:609–622.
Warren J, Piatt R, Thomas R, et al. Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med 1978;299:570–573.
Saint S. Clinical and economic consequences of nosocomial catheter related bacteriuria. Am J Infect Control 2000;28:68–75.
Silveira F, Fujitani S, Paterson D. Antibiotic-resistant infections in the critically ill adult. Clin Lab Med 2004;24:329–341.
Wagenlehner F, Naber, K. Hospital-acquired urinary tract infections. J Hosp Infect 2000;46:171–181.
Tambyah P. Catheter-associated urinary tract infections: diagnosis and prophylaxis. Int J Antimicrob Agents 2004;24S;S44–S48.
Tambyah P, Halvorson K, Maki D. A prospective study of the pathogenesis of catheter-associated urinary tract infection. Mayo Clin Proc 1999;74:131–136.
Piatt R, Polk B, Murdock B, et al. Risk factors for nosocomial urinary tract infection. Am J Epidemiol 1986;124:977–985.
Johnson J, Roberts P, Olsen R, et al. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis 1990;162:1145–1150.
Riley D, Classen D, Stevens L, et al. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med 1995;98:349–356.
Stark R, Maki D. Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med 1984;311:560–564.
Urinary Tract Infection (UTI) Working Group: Naber K, Bergman B, et al. EAU guidelines for the management of urinary and male genital tract infections. Eur Urol 2001;40:576–588.
Tambyah P, Maki D. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1497 catheterized patients. Arch Intern Med 2000;160:678–682.
Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002;113:14S–19S.
Wagenlehner F, Naber K. New drugs for gram-positive uropathogens. Int J Antimicrob Agents 2004;24S:S39–S43.
Carson C, Naber K. Role of fluroquinolones in the treatment of serious bacterial urinary infections. Drugs 2004;64:1359–1373.
Talan D, Klimberg I, Nicolle L, et al. Once daily extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 2004;171:734–739.
Maki D, Tambyah P. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 2001;7:342–347.
Ouslander J, Greengold B, Chen S. External catheter use and urinary tract infections among incontinent male nursing home patients. J Am Geriatr Soc 1987;35:1063–1070.
Huth T, Burke J, Larsen R, et al. Clinical trial of junction seals for the prevention of urinary catheter-associated bacteriuria. Arch Intern Med 1992;152:807–812.
Kunin C, McCormack R. Prevention of catheter-induced urinary-tract infections by a new sterile closed drainage system. Antimicrobial Agents Chemother 1965;5:631–638.
Classen D, Larsen R, Burke J, et al. Prevention of catheter-associated bacteriuria: clinical trial of methods to block three known pathways of infection. Am J Infect Control 1991;19:136–142.
Darouiche R, Smith J, Hanna H, et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 1999;54:976–981.
Karchmer T, Giannetta E, Muto C, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 2000;160:3294–3298.
Johnson J, Roberts P, Olsen R, et al. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis 1990;162:1145–1150.
Saint S, Elmore J, Sullivan S, et al. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 1998;105:236–241.
Karchmer T, Giannetta E, Muto C, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 2000;160:3294–3298.
Maki D, Knasinski V, Halvorson K, et al. A novel silver hydro-gel-impregnated indwelling urinary catheter reduces catheter related urinary tract infections: a prospective double-blind trial [abstract]. Infect Control Hosp Epidemiol 1998;19:682.
Thibon P, Le Coutour X, Leroyer R, et al. Randomized multicentre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J Hosp Infect 2000;45:117–124.
Verleyen P, De Ridder D, Van Poppel H, et al. Clinical application of the Bardex IC Foley catheter. Eur Urol 1999;36:240–246.
Bologna R, Tu L, Polansky M, et al. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology 1999;54:982–987.
Gerding D, Johnson S, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459–477.
Archibald L, Banerjee S, Jarvis W. Secular trends in hospital-acquired C. difficile disease in the United States 1897–2001. J Infect Dis 2004;189:1585–1589.
Oldfield E. Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment. Rev Gastroenterol Disord 2004;4:186–195.
Bricker E, Garg R, Nelson R. Antibiotic treatment of Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev 2005,1CD 004610, pub2.
Vandenbussche T, De Moor S, Bachert C, et al. Value of antral puncture in the intensive care patient with fever of unknown origin. Laryngoscope 2000;110:1702–1706.
LeMoal G, Lemerre D, Grollier G, et al. Nosocomial sinusitis with isolation of anaerobic bacteria in ICU patients. Intensive Care Med 1999;25:1066–1071.
Merle V, Germain JM, Bugel H, et al. Nosocomial urinary tract infections in urologic patients: assessment of a prospective surveillance program including 10,000 patients. Eur Urol 2002;41:48–49.
Jones RN, Kugler KC, Pfaller MA, et al. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program 1997. Diagn Microbiol Infect Dis 1999;35:55–63.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lipsett, P.A. (2008). Nosocomial Infections. In: Norton, J.A., et al. Surgery. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68113-9_14
Download citation
DOI: https://doi.org/10.1007/978-0-387-68113-9_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-30800-5
Online ISBN: 978-0-387-68113-9
eBook Packages: MedicineMedicine (R0)